Dexmethylphenidate Hydrochloride

Attention Deficit Hyperactivity Disorder

Treatment

1 FDA approval

20 Active Studies for Dexmethylphenidate Hydrochloride

What is Dexmethylphenidate Hydrochloride

Dexmethylphenidate

The Generic name of this drug

Treatment Summary

Dexmethylphenidate is a stimulant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and was introduced in 2002. It is the dextrorotary form of methylphenidate and is thought to be more effective than the l-isomer or the racemic mixture and have fewer side effects.

Ritalin

is the brand name

image of different drug pills on a surface

Dexmethylphenidate Hydrochloride Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Ritalin

Dexmethylphenidate

1955

400

Approved as Treatment by the FDA

Dexmethylphenidate, otherwise known as Ritalin, is approved by the FDA for 1 uses including Attention Deficit Hyperactivity Disorder .

Attention Deficit Hyperactivity Disorder

Helps manage Attention Deficit Hyperactivity Disorder (ADHD)

Effectiveness

How Dexmethylphenidate Hydrochloride Affects Patients

Dexmethylphenidate is a form of the drug methylphenidate, which is more active in the body than the regular version. It works by preventing norepinephrine and dopamine from being taken up in the brain.

How Dexmethylphenidate Hydrochloride works in the body

Methylphenidate works by preventing dopamine and norepinephrine from being reabsorbed into brain cells. This means that more of these chemicals can be present in the brain for a longer period of time. Studies have shown that this can result in increased blood flow to certain parts of the brain, such as the striatum, supplementary motor area, and posterior parietal cortex.

When to interrupt dosage

The quantity of Dexmethylphenidate Hydrochloride is based on the diagnosed condition. The dosage fluctuates depending on the administration technique (e.g. Tablet, film coated, extended release or Capsule, extended release) indicated in the table below.

Condition

Dosage

Administration

Attention Deficit Hyperactivity Disorder

, 5.0 mg, 10.0 mg, 20.0 mg, 30.0 mg, 40.0 mg, 15.0 mg, 25.0 mg, 35.0 mg, 2.5 mg, 10.0 mg/mL, 5.0 mg/mL, 18.0 mg, 36.0 mg, 27.0 mg, 54.0 mg, 72.0 mg, 85.0 mg, 55.0 mg, 45.0 mg, 70.0 mg, 80.0 mg, 60.0 mg, 100.0 mg, 50.0 mg, 10.4 mg, 6.0 mg/mL, 5.2 mg, 9.0 mg/mL, 30.0 mg/mL, 7.5 mg/mL, 7.8 mg, 1.0 mg/mL, 2.0 mg/mL

, Oral, Capsule, extended release, Capsule, extended release - Oral, Tablet, Tablet - Oral, Capsule, Capsule - Oral, Solution - Oral, Solution, Tablet, chewable, Tablet, extended release, Tablet, extended release - Oral, Tablet, chewable - Oral, Suspension, extended release - Oral, Suspension, extended release, Tablet, Chewable, Extended Release, Tablet, Chewable, Extended Release - Oral, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release

Warnings

Dexmethylphenidate Hydrochloride Contraindications

Condition

Risk Level

Notes

Gilles de la Tourette syndrome

Do Not Combine

Tension-Type Headache

Do Not Combine

Agitation

Do Not Combine

Pulse Frequency

Do Not Combine

Tourette Syndrome

Do Not Combine

Tics

Do Not Combine

Generalized Anxiety Disorder

Do Not Combine

Open-angle glaucoma

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Dexmethylphenidate may interact with Pulse Frequency

There are 20 known major drug interactions with Dexmethylphenidate Hydrochloride.

Common Dexmethylphenidate Hydrochloride Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Desflurane

Major

Dexmethylphenidate may increase the hypertensive activities of Desflurane.

Diethyl ether

Major

Dexmethylphenidate may increase the hypertensive activities of Diethyl ether.

Enflurane

Major

Dexmethylphenidate may increase the hypertensive activities of Enflurane.

Ethanol

Major

Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Dexmethylphenidate Hydrochloride Toxicity & Overdose Risk

Dexmethylphenidate has the same effect in men and women. It is unclear if there are different effects on different races, children under 6 years old, people with kidney or liver problems, pregnant or breastfeeding women, or elderly people. Kidney issues should not affect the dose of dexmethylphenidate as it is not mainly cleared by the kidneys. Animal studies have shown that taking this drug during pregnancy can slow down the development of bones in the fetus, and can lead to reduced weight gain in male offspring. The benefits and risks should be carefully weighed before taking this drug. Animal studies suggest that dexmethylphenidate may cause liver tumors and

image of a doctor in a lab doing drug, clinical research

Dexmethylphenidate Hydrochloride Novel Uses: Which Conditions Have a Clinical Trial Featuring Dexmethylphenidate Hydrochloride?

77 active investigations are examining the potential of Dexmethylphenidate Hydrochloride to manage Attention Deficit Hyperactivity Disorder.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

61 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2

Dexmethylphenidate Hydrochloride Reviews: What are patients saying about Dexmethylphenidate Hydrochloride?

5

Patient Review

2/19/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I only get headaches every once in a while, and I actually lost weight in the first few months. However, that has since leveled off.

5

Patient Review

2/19/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I only got occasional headaches from this treatment, and I actually lost a few pounds in the first few months. It's been really great!

4.7

Patient Review

2/19/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I've tried a lot of different treatments for my son's ADHD, and this one seems to be working the best so far. He's on 20mg in the morning and another 20mg at lunchtime, five hours later. No problems with side effects that we can tell.

4.7

Patient Review

2/19/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I've tried a lot of different treatments for my son's ADHD, and this one seems to be working better than the others. I'm hesitant to increase the dosage as recommended by his doctor, but so far he's been doing well on it.

4

Patient Review

8/1/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

This medication has helped me be able to focus on my work, school, and family life. I would recommend it to other adults who have trouble focusing.

4

Patient Review

8/1/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

This medication helped me be able to focus a lot better. I'm now able to work full-time, take care of my three kids, and still have time to work on my degree plans. I definitely noticed a difference in how well I was able to pay attention to details and get things done.

3.7

Patient Review

5/1/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

We've been using Focalin XR for a little over a year now. It's helped my son, but he has zero appetite while the drug is active (which lasts about 7 hours). Additionally, his hyperactivity gets worse after the effects of the medication wear off. We had to start giving him Melatonin at night so that he could settle down and sleep. We're currently investigating other options for longer-term treatment.

3.7

Patient Review

10/16/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My son was prescribed Ritalin, but it would wear off too quickly and he'd lose focus in school. His doctor recommended Focalin as a time-release option, and we've seen great results so far. He hasn't had any changes to his sleep or eating patterns, and there haven't been any negative side effects that we've noticed.

3.7

Patient Review

4/17/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My son has been on this medication for eight months. The first few were great, but then he started becoming irritable and developed anxiety and thoughts of harming himself. I'm looking to switch medications, but his doctor seems to think we can power through these side effects.

3.7

Patient Review

4/17/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My son has been on this medication for eight months. At first, it was going great; however, a few months ago I started to notice his irritability. He's also developed anxiety and now he's having harmful thoughts of hurting himself. An 8-year-old shouldn't be experiencing these things.

3.7

Patient Review

5/1/2015

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My son has been taking Focalin XR for a little over a year now. I am satisfied for the most part; however, he has complete lack of appetite for the 7 hours the drug actually works (compensating in the evenings by eating 3 plates at dinner). In addition, his hyperactivity after the drug wears off is significantly increased. We had to start him on Melatonin at night to settle his mind and get him to sleep. We are looking into a longer lasting medication.

3.7

Patient Review

10/16/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

So far, this has been a much better option for my son than Ritalin. He's able to focus longer and there haven't been any negative side effects that we've seen.

3.3

Patient Review

2/19/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I was diagnosed with ADHD and this treatment has helped me a lot.

3.3

Patient Review

2/19/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

this helps with my adhd but i still have some problems

3

Patient Review

7/29/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I took this at 2pm and by 3pm, just one hour later, I noticed it wearing off. I was disappointed because I thought XR meant it was time-released.

3

Patient Review

7/29/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I first took this medication at 2pm, and by 3pm I noticed it wearing off. Maybe it just didn't work well for me, but I was expecting the XR version to last longer since it's supposed to be time-released.

2.7

Patient Review

8/21/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I saw no change in my daughter after using this treatment. If anything, it made her more lost and unattentive.

2.7

Patient Review

8/21/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I saw no real change in my daughter after using this treatment. If anything, she seemed more lost and unattentive than before.

2.3

Patient Review

1/25/2022

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I didn't enjoy this medication from the start. It also doesn't last very long, which is frustrating. I feel nauseous and down when it wears off, so I'm not looking forward to trying a different variation of this drug.

2.3

Patient Review

8/3/2022

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

This medicine had some short-term benefits, but after a while, I started to lose weight and look very sick. I was more focused, but I wasn't my usual happy self. I felt like a zombie.

2.3

Patient Review

1/25/2022

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I didn't enjoy this medication from the start. It also only lasted for a few hours, which was frustrating. Additionally, I felt nauseous and down when it wore off. My doctor wants me to try regular Focalin next, but I'm not hopeful that it will be any better.

2.3

Patient Review

8/3/2022

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

I tried this treatment as a child at the suggestion of my mother. It was effective for a short while, but then I started losing weight and looking very sick. I wasn't myself at all while taking this medication; rather, I felt like a zombie.

2

Patient Review

6/24/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My child has been dealing with a lot of anxiety and fearfulness.

2

Patient Review

6/24/2014

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

My child has been very anxious and fearful

1.7

Patient Review

4/7/2021

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

This was a big help in terms of calming my mind, but I started experiencing some very severe mood swings. Once I stopped taking the medication, those feelings went away.

1.7

Patient Review

4/7/2021

Dexmethylphenidate Hydrochloride for Attention Deficit Disorder with Hyperactivity

This was a marked improvement from other common stimulants I had tried, in that it actually helped to calm my mind. For the first time in a long while, my thoughts were quiet and at peace. However, I started experiencing severe mood swings in the evening hours; becoming enraged and throwing things. Once I was taken off the medication by my doctor, those feelings stopped entirely.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about dexmethylphenidate hydrochloride

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is dexmethylphenidate a Ritalin?

"Derivatives of methylphenidate (Ritalin, Concerta, Metadate, etc.) include dexmethylphenidate, which is a man-made stimulant."

Answered by AI

Is dexmethylphenidate hydrochloride the same as Adderall?

"Adderall and Focalin differ in that Adderall contains four types of amphetamine salt, while Focalin only contains one. Another key difference is that there is no generic form of Vyvanse, making it more expensive than Adderall."

Answered by AI

What does dexmethylphenidate hydrochloride do?

"Dexmethylphenidate is a medication used to treat attention deficit hyperactivity disorder (ADHD). It is classified as a central nervous system (CNS) stimulant. Dexmethylphenidate works by increasing attention and decreasing restlessness in patients who are hyperactive, have difficulty concentrating, or are easily distracted."

Answered by AI

Is dexmethylphenidate hydrochloride a narcotic?

"Focalin is a Schedule II controlled substance in the U.S., meaning it has a high potential for abuse and dependence."

Answered by AI

Clinical Trials for Dexmethylphenidate Hydrochloride

Image of Seattle Children's Hospital in Seattle, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Seattle, WA

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Seattle Children's Hospital

Image of St. Jude Children's Research Hospital in Memphis, United States.

Methylphenidate for Sickle Cell Disease

8 - 17
All Sexes
Memphis, TN

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study will assess any thinking or attention problems participants may have both before taking this drug and after. Additionally, the study will assess the decision-making process of the caregiver that may influence using this drug or not. Primary Objective: • Assess the feasibility, acceptability, and adherence to MPH treatment in children with SCD and EF deficits. Secondary Objective: • Evaluate neurobehavioral and safety outcomes following MPH treatment. Exploratory Objective: • Evaluate decision-making and determinants influencing methylphenidate utilization among parents.

Phase 1
Recruiting

St. Jude Children's Research Hospital

Andrew Heitzer, PhD

Have you considered Dexmethylphenidate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Dexmethylphenidate Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of The University of Iowa in Iowa City, United States.

fMRI for Cognitive Flexibility

18 - 35
All Sexes
Iowa City, IA

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Waitlist Available
Has No Placebo

The University of Iowa

Image of UCSF Nancy Friend Pritzker Psychiatry Building in San Francisco, United States.

Trigeminal Nerve Stimulation for ADHD in Children with Autism

7 - 14
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Recruiting
Device

UCSF Nancy Friend Pritzker Psychiatry Building

Image of The University of Texas at Austin in Austin, United States.

Transcranial Photobiomodulation for ADHD

18 - 44
All Sexes
Austin, TX

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Waitlist Available
Online Trial

The University of Texas at Austin

Have you considered Dexmethylphenidate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Dexmethylphenidate Hydrochloride, we think they might fit your search criteria.
Go to Trials
Image of Louisiana State University in Baton Rouge, United States.

Virtual Reality for ADHD

18 - 25
All Sexes
Baton Rouge, LA

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Phase 4
Waitlist Available

Louisiana State University (+1 Sites)

Joshua M Langberg, PhD

Image of Duke University in Durham, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Durham, NC

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Duke University

John Mitchell, PhD

Image of Kennedy Krieger Institute in Baltimore, United States.

Iron Supplementation for ADHD and Restless Sleep

8 - 18
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment

Phase 1 & 2
Waitlist Available

Kennedy Krieger Institute

Alison E Pritchard, PhD

Image of Montana State University in Bozeman, United States.

Speech-Gesture Combinations for Autism

Any Age
All Sexes
Bozeman, MT

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Recruiting
Has No Placebo

Montana State University

Have you considered Dexmethylphenidate Hydrochloride clinical trials?

We made a collection of clinical trials featuring Dexmethylphenidate Hydrochloride, we think they might fit your search criteria.
Go to Trials